Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lisa F-P Ng

Showing results (111-120 of 165) with videos related to

Pageof 17
Sort By:
Journal of Leukocyte Biology|May 22, 2025
Early neutrophil responses are potential biomarkers to predict severe COVID-19 in adultsAnanya Singh, Nurhidayah Binte Mohamed Yazid, Raika Francesca Morales, et al.
Vaccines|April 23, 2025
SARS-CoV-2 mRNA Vaccines Induce Cross-Reactive Antibodies to NL63 Coronavirus but Do Not Boost Pre-Existing Immunity Anti-NL63 Antibody ResponsesWeiyi Tang, Zi Wei Chang, Yun Shan Goh, et al.
Open Forum Infectious Diseases|June 7, 2021
Persistent Symptoms and Association With Inflammatory Cytokine Signatures in Recovered Coronavirus Disease 2019 PatientsSean Wei Xiang Ong, Siew-Wai Fong, Barnaby Edward Young, et al.
Journal of Leukocyte Biology|March 20, 2025
Early neutrophil responses are potential biomarkers to predict severe COVID-19 in adultsAnanya Singh, Nurhidayah Binte Mohamed Yazid, Raika Francesca Morales, et al.
Aging Cell|February 6, 2024
Relative deficiency in interferon-γ-secreting CD4+ T cells is strongly associated with poorer COVID-19 vaccination responses in older adultsVanda W T Ho, Low Heng Boon, Jianzhou Cui, et al.
Iscience|October 31, 2025
Human indels as predictors of antibody responses to COVID-19 vaccinesHsiuyi V Chen, Siew-Wai Fong, Yun Shan Goh, et al.
Trials|June 16, 2022
Evaluation of the safety and immunogenicity of different COVID-19 vaccine combinations in healthy individuals: study protocol for a randomized, subject-blinded, controlled phase 3 trial [PRIBIVAC]Xuan Ying Poh, I Russel Lee, Clarissa Lim, et al.
The Journal of Infectious Diseases|March 5, 2024
Functional and Immunologic Mapping of Domains of the Reticulocyte-Binding Protein Plasmodium vivax PvRBP2aMatthew Zirui Tay, Weiyi Tang, Wenn-Chyau Lee, et al.
Scientific Reports|March 7, 2018
Efficient detection of Zika virus RNA in patients' blood from the 2016 outbreak in Campinas, BrazilCarla Cristina Judice, Jeslin J L Tan, Pierina Lorencini Parise, et al.
Journal of Medical Virology|February 16, 2022
Discrepant serological findings in SARS-CoV-2 PCR-negative hospitalized patients with fever and acute respiratory symptoms during the pandemicGail B Cross, Claire M Naftalin, Jinghao N Ngiam, et al.
Pageof 17

Showing results (111-120 of 165) with videos related to

Sort By:
Pageof 17
Journal of Leukocyte Biology|May 22, 2025
Early neutrophil responses are potential biomarkers to predict severe COVID-19 in adultsAnanya Singh, Nurhidayah Binte Mohamed Yazid, Raika Francesca Morales, et al.
Vaccines|April 23, 2025
SARS-CoV-2 mRNA Vaccines Induce Cross-Reactive Antibodies to NL63 Coronavirus but Do Not Boost Pre-Existing Immunity Anti-NL63 Antibody ResponsesWeiyi Tang, Zi Wei Chang, Yun Shan Goh, et al.
Open Forum Infectious Diseases|June 7, 2021
Persistent Symptoms and Association With Inflammatory Cytokine Signatures in Recovered Coronavirus Disease 2019 PatientsSean Wei Xiang Ong, Siew-Wai Fong, Barnaby Edward Young, et al.
Journal of Leukocyte Biology|March 20, 2025
Early neutrophil responses are potential biomarkers to predict severe COVID-19 in adultsAnanya Singh, Nurhidayah Binte Mohamed Yazid, Raika Francesca Morales, et al.
Aging Cell|February 6, 2024
Relative deficiency in interferon-γ-secreting CD4+ T cells is strongly associated with poorer COVID-19 vaccination responses in older adultsVanda W T Ho, Low Heng Boon, Jianzhou Cui, et al.
Iscience|October 31, 2025
Human indels as predictors of antibody responses to COVID-19 vaccinesHsiuyi V Chen, Siew-Wai Fong, Yun Shan Goh, et al.
Trials|June 16, 2022
Evaluation of the safety and immunogenicity of different COVID-19 vaccine combinations in healthy individuals: study protocol for a randomized, subject-blinded, controlled phase 3 trial [PRIBIVAC]Xuan Ying Poh, I Russel Lee, Clarissa Lim, et al.
The Journal of Infectious Diseases|March 5, 2024
Functional and Immunologic Mapping of Domains of the Reticulocyte-Binding Protein Plasmodium vivax PvRBP2aMatthew Zirui Tay, Weiyi Tang, Wenn-Chyau Lee, et al.
Scientific Reports|March 7, 2018
Efficient detection of Zika virus RNA in patients' blood from the 2016 outbreak in Campinas, BrazilCarla Cristina Judice, Jeslin J L Tan, Pierina Lorencini Parise, et al.
Journal of Medical Virology|February 16, 2022
Discrepant serological findings in SARS-CoV-2 PCR-negative hospitalized patients with fever and acute respiratory symptoms during the pandemicGail B Cross, Claire M Naftalin, Jinghao N Ngiam, et al.
Pageof 17